论文部分内容阅读
目的探讨2型糖尿病患者及其合并脑梗塞患者中血浆脂联素水平的变化。方法选取2型糖尿病患者83例(A组)、合并脑梗塞患者20例(B组)、健康对照者35例(C组)作为研究对象。测定受试者血浆脂联素水平、血压、体重等,比较脂联素水平的改变,以及与其它因素的相关性。结果A组血浆脂联素水平明显低于C组(P<0.01),B组血浆脂联素又明显低于A组(P<0.01)。在糖尿病患者中,血浆脂联素与收缩压(SBP)呈负相关(r=-0.309,P<0.01)。结论对2型糖尿病患者及2型糖尿病合并脑梗塞者检测血浆脂联素水平具有临床诊断价值。
Objective To investigate the changes of plasma adiponectin level in type 2 diabetes mellitus patients with cerebral infarction. Methods 83 patients with type 2 diabetes mellitus (group A), 20 patients with cerebral infarction (group B) and 35 healthy controls (group C) were selected as subjects. Subjects were measured plasma adiponectin levels, blood pressure, body weight, etc., compared with changes in adiponectin levels, and with other factors. Results The level of plasma adiponectin in group A was significantly lower than that in group C (P <0.01). The level of plasma adiponectin in group B was significantly lower than that in group A (P <0.01). In patients with diabetes, plasma adiponectin and systolic blood pressure (SBP) was negatively correlated (r = -0.309, P <0.01). Conclusion It is of clinical value to detect plasma adiponectin level in patients with type 2 diabetes mellitus and type 2 diabetes with cerebral infarction.